ATP13A2 and Parkinson disease: Decreased expression of Atp13a2 is also associated with defective autophagy in midbrain dopaminergic neurons from a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease mouse model (Wan et al., 2020).